US FDA approves J&J's oral psoriasis pill - Reuters
US FDA approves J&J's oral psoriasis pill Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQbGRxR1liVUpqNVc2NEJGUVBmRGFLOWR1TmI1X3dIOWhOQzVnVk1MYzVtLUFCZ0tMZE1CWWQ3dXhlSURGMmJ3TlVuWXZaWk4wZGg1X1B1X2ZNNnBSMm04V3UtTTlTcW1NY0lpUXRHTWZ4d1A5ZDJWMy1xeE1ieEJtMXc4dmRYY2J4YVNjZUVKcm1zUWFqNFU5TTNtVVlENWlMOEZ5OEtjS3lIMTNsd0RtRw?oc=5" target="_blank">US FDA approves J&J's oral psoriasis pill</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMUS FDA approves Asahi Kasei's drug for persistent herpes infections - Reuters
US FDA approves Asahi Kasei's drug for persistent herpes infections Reuters
October 9, 2026 at 06:01 PMTeva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMUS FDA flags four deaths in Newron's schizophrenia drug studies - Reuters
US FDA flags four deaths in Newron's schizophrenia drug studies Reuters
October 8, 2026 at 05:47 PMHalozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
October 7, 2026 at 05:03 PMArgenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PM